Results bivalirudin use in actual practice in patients with acute coronary syndrome during percutaneous coronary intervention

Abstract

Presents the results of the use of Bivalirudin in actual practice in patients with acute coronary syndrome during percutaneous coronary intervention (PCI). Demonstrated high efficiency of Bivalirudin in the amount of bleeding occurring in the postoperative period and adverse cardiovascular complications.

Keywords

• бивалирудин
• острый коронарный синдром
• кровотечение
• сердечно-сосудистые осложнения